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ETB Receptor in Renal Medulla Is Enhanced by Local
Sodium During Low Salt Intake
Simone Vanni, Gianluca Polidori, Ilaria Cecioni, Sergio Serni, Marco Carini, Pietro Amedeo Modesti
Abstract—Renal endothelin-1 participates in sodium and water handling, and its urinary excretion is increased in
sodium-retentive states. We compared the cortical and medullary renal expression of prepro-endothelin-1, endothelin-
converting enzyme-1, and endothelin type A and type B receptors in patients who underwent nephrectomy after normal
(108 mmol/d NaCl; n6) or low (20 mmol/d NaCl; n6) sodium diet and investigated whether sodium exerts a direct
role on endothelin receptor binding in vitro. With normal sodium diet prepro-endothelin-1 mRNA was 3-fold higher in
renal medulla than in cortex (P0.01), whereas endothelin-converting enzyme-1 mRNA was equally distributed.
Endothelin-1 receptor density was 2-fold higher in renal medulla than in cortex (P0.05). Type B was the main receptor
subtype in both regions. In the renal cortex, low sodium diet caused a 194% increase in prepro-endothelin-1 mRNA
(P0.05), whereas endothelin-converting enzyme-1 type B and type A receptors remained unchanged. In contrast, in
the renal medulla the increase in prepro-endothelin-1 mRNA (30%, P0.05) was associated with a selective increase
in type B receptor for both mRNA expression (37%, P0.05) and binding density (55%, P0.05). Increasing in
vitro sodium concentrations between 154 and 308 mmol/L significantly enhanced type B receptor density (P0.05) and
affinity (P0.05). In conclusion, during low sodium diet, renal prepro-endothelin-1 synthesis increases mainly in the
renal cortex (where no changes in receptors occur), whereas type B receptor is selectively enhanced in the renal medulla.
The range of sodium concentrations that are physiologically present in vivo in the renal medulla selectively modulate
type B receptor density and affinity. (Hypertension. 2002;40:179-185.)
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Renal endothelin (ET)-1 is produced by vascular endothe-lium in the cortex, including glomerular capillaries,
arterioles, and peritubular capillaries, and by tubular epithe-
lial cells in the inner medulla.1,2 These 2 compartments
represent 2 distinct systems, both involved in volume ho-
meostasis. ET-1 produced in the vasculature by endothelial
cells is able to reduce blood flow at the renal cortex by acting
on endothelin type A (ETA) receptor subtype.3 This vascular
ETA-mediated effect results in increased sodium reabsorption
in both humans3,4 and experimental animals.5 Conversely,
ET-1 produced by tubular epithelial cells inhibits arginine
vasopressin (AVP)-stimulated osmotic water permeability in
inner medullary collecting ducts6–8 via endothelin type B
(ETB) receptor subtype,5,9 thus increasing free water
clearance.2
There is in vitro evidence that the increased osmolality
increases preproET-1 (ppET-1) mRNA expression and ET-1
synthesis in epithelial tubular cells.10,11 In vivo, an increased
renal ET-1 production has been found in pathophysiological
and clinical conditions characterized by increased medulla
osmolarity, such as dehydrated physical exercise,12 low so-
dium diet,2 and heart failure.13
However, although cortical and medullary ET-1 systems
participate differently in sodium and water handling, no
studies exist comparing the activation of the ET-1 system in
the 2 renal regions in the sodium-retentive states. Moreover,
despite the fact that the use of ET-1 receptor antagonist has
been proposed in heart failure,14–16 no information is avail-
able as to whether the increased local ET-1 synthesis is
associated with a consensual increase in receptor synthesis or
whether it may cause downregulation of its specific receptors.
Therefore, the aims of this study are to compare the effects
of low sodium diet on the expression of the various ET-1
system components (ppET-1, endothelin-converting enzyme
[ECE]-1, ETA, and ETB) in the cortex and in renal medulla
and to investigate whether sodium might play a direct role on
endothelin receptor binding density and affinity.
Methods
Subjects Investigated and Experimental Protocol
Twelve patients affected by polar tumor and listed for elective
nephrectomy were investigated. No subject was a smoker or had
taken any drug for at least 4 weeks. Patients with hypertension,
ischemic heart disease, heart failure, renal failure, abnormal liver
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function tests or diabetes were excluded. The study was approved by
the local review committee of the University of Florence, and all
subjects gave their informed, written consent.
During the week preceding surgery, patients were randomized to
receive a 7-day period of the same basic diet, with either normal
(108 mmol/d NaCl; n6) or low (20 mmol/d NaCl; n6) sodium
intake. Urine and plasma samples for the determination of sodium,
creatinine, and plasma renin activity (PRA) were taken daily during
the last 3 days of each diet regimen (Table 1).
Transmural kidney specimens, containing both cortex and me-
dulla, were cut from the pole opposite the tumor and fixed in 4%
paraformaldehyde for in situ hybridization studies. In addition,
separated specimens of whole medulla (containing both inner and
outer medulla) and cortex were dissected immediately after nephrec-
tomy and frozen in liquid nitrogen for binding and RT-PCR studies.
Receptor Binding Studies
Cell membranes were obtained from homogenated tissue as previ-
ously described.17 Competition and kinetic studies were performed
in the presence of increasing concentrations of NaCl or NaH2PO4 (0,
77, 154, 231, and 308 mmol/L). Experiments were carried out in
triplicate, and separate curves for renal cortex and medulla were
obtained in each patient.
Equilibrium Binding Studies
Cell membranes (250 g/mL) were incubated with 125I-ET-1 (100
pmol/L, 2000 Ci/mmol) (Amersham) and increasing concentrations
of unlabeled ET-1 (0 to 1 mol/L) or selective ETA (BQ123, 0 to 100
mol/L) and ETB (BQ788, 0 to 100 mol/L) antagonists for 120
minutes at 22°C in a final volume of 0.2 mL.17 The content was then
rapidly filtered through glass fiber filters (Whatman GF/C). Binding
data were analyzed using a nonlinear fitting computer program
(LIGAND).18
Kinetic Analysis
The kinetics of association of 125I-ET-1 (100 pmol/L) to cell
membranes (250 g/mL) were evaluated as previously described.19
RT-PCR Analysis
Levels of ppET-1, ECE-1, ETA, and ETB transcripts were quantified
with reverse transcription-polymerase chain reaction (RT-PCR) us-
ing specific primers (Table 2) with GAPDH as the internal standard
as previously described.17 The efficiency of amplification of each
primer pair was calculated beforehand from the slope of the
semilogarithmic relationship between cycles of amplification (26 to
44) and amplification products (23% for GAPDH, 23% for ppET-1,
22% for ECE-1, and 22% for both ETA and ETB receptors) (Figure
1). All RT-PCR studies were performed in triplicate in all subjects
investigated.
In Situ Hybridization Studies
In situ hybridization studies were performed as previously described2
using specific cDNA probes for ETA and ETB receptor subtypes
(ETA, American Type Culture Collection, ATCC 105194, and ETB,
ATCC 1250426) and for GAPDH (ATCC 57090).
Statistical Analysis
Data are presented as meanSD. Comparisons of a single observa-
tion between groups were made with ANOVA and 2-tailed t tests.
All statistical analyses were performed with BMDP statistical
software (BMDP Statistical Software, Inc).
Results
Renal ET-1 System
RT-PCR showed that the ppET-1/GAPDH ratio was 3-fold
higher in renal medulla than in cortex (1.010.1 versus
0.310.24, respectively; P0.01), whereas there was a
comparable presence of ECE-1 mRNA in the 2 regions
(ECE-1/GAPDH ratios of 0.850.45 and 0.780.44, respec-
tively) (Figure 2A).
ETB mRNA was the prevalent receptor transcript in both
medulla (1.210.08 and 0.390.12 for ETB/GAPDH and
ETA/GAPDH ratios, respectively) and renal cortex
(0.950.33 and 0.450.14, respectively) (Figure 2A). In situ
hybridization studies showed that mRNA for ETB receptor
was mainly expressed by tubular epithelial cells in renal
medulla, whereas the ETA subtype was almost exclusively








GAPDH 5 TGAAGGTCGGAGTCAACGGA 987 58 32
3 CATGTGGGCCATGAGGTCCA
ppET-1 5 GTCAACACTCCCGAGCACGTT 304 60 32
3 CTGGTTTGTCTTAGGTGTTCCTC
ECE-1 5 TGCCATCTACAACATGATAG 572 52 32
3 GTCTTGACCCACTTCTTC
ETA 5 TATCAATGTATTTAAGCTGCTGG 252 56 35
3 GGAATGGCCAGGATAAAGG
ETB 5 TTGGAGCTGAGATGTGTAAGC 626 56 35
3 CCATAGTTGTACCGAAGTGAC





Age, y 533 557
Gender, M/F 4/2 3/3
Systolic arterial pressure, mm Hg 1257 1288
Diastolic arterial pressure, mm Hg 823 833
Plasma glucose, mg/dL 806 817
Plasma sodium, mEq/L 1394 1375
Plasma creatinine, mg/dL 0.970.25 0.930.32
Creatinine clearance, mL/min 937 949
Sodium clearance, mL/min 0.60.04 0.090.03*
Plasma renin activity, ng Ang I/mL per hour 1.580.32 4.340.24*
Ang I indicates angiotensin I.
*P0.05 vs normal sodium intake.
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localized in the endothelial cells of peritubular vessels (Fig-
ure 2B).
With binding studies, ET-1 receptor density was 2-fold
higher in renal medulla than in cortex (12713 versus 599
fmol/mg protein, P0.05) (Table 3). Again with binding
studies, receptor population was almost exclusively repre-
sented by the ETB subtype in both districts (80%) (Figure
3), with a 2.3-fold higher maximum binding (Bmax) in renal
medulla than in renal cortex (Table 3). No differences in
receptor affinity were observed between renal medulla and
renal cortex.
Effect of Low Sodium Diet
In renal cortex, only mRNA for ppET-1 was markedly
increased (194% versus normal sodium diet) whereas
mRNAs for ECE-1 and receptor subtypes remained un-
changed (Figure 4). No changes in receptor binding were
found in renal cortex (Table 3).
Conversely, in renal medulla, both ppET-1 and ETB genes
were significantly enhanced (30% and37%, respectively;
P0.05 for both) without any changes in ECE-1 and ETA
transcripts. Binding studies confirmed the selective increase
in ETB receptor density in renal medulla during low sodium
diet (55% versus normal sodium diet) with no modifica-
tions in the ETA subtype (Table 3, Figure 5).
Effect of Sodium In Vitro
ETB receptor density and affinity showed a sodium-dependent
increase in renal medullary membranes obtained from pa-
tients on normal sodium diet (Table 3, Figure 6). The increase
was significant for NaCl concentrations greater than
154 mmol/L because, at 154 mmol/L, ETB receptor density
was increased by 15% versus NaCl-free buffer (NS), whereas
at 231 and 308 mmol/L increased by 28% (P0.05 versus
NaCl-free buffer) and 49% (P0.05 versus both NaCl-free
buffer and 154 mmol/L NaCl).
Likewise, the binding affinity remained almost unchanged
versus NaCl-free buffer up to 154 mmol/L NaCl (1.5-fold,
NS), and was 3.2-fold and 3.8-fold enhanced at 231 and
308 mmol/L NaCl, respectively (P0.05 versus NaCl-free
and 154 mmol/L NaCl for both) (Table 3).
In addition, the same effect was observed with membranes
isolated from renal cortex. The relationship between the KR
product of ET-1 binding (a unitless measure of the amount of
Figure 1. A, Amplification of GAPDH,
endothelin type A (ETA) and type B (ETB)
receptors, prepro-endothelin (ppET)-1,
and endothelin-converting enzyme
(ECE)-1 in human renal medulla at
increasing numbers of cycles (26 to 44).
B, Semilogarithmic representation of the
relative extent of amplification (Y) of
GAPDH, ETA and ETB receptors, ppET-1,
and ECE-1.
Figure 2. Expression of the components
of the ET-1 system in human kidney. A,
Representative RT-PCR of mRNA
expression for ppET-1, ECE-1, and
GAPDH (upper panel) and for ETA and
ETB receptors and GAPDH (lower panel)
in human kidney at normal sodium diet
(n6). Ratio to GAPDH mRNA expres-
sion is reported. *P0.01 versus
medulla. B, In situ hybridization studies
for ETA and ETB receptor mRNAs in renal
medulla and renal cortex. Prevalent ETB
expression on tubular epithelial cells in
renal medulla. Localization of ETA sub-
type in interstitial and endothelial cells of
peritubular vessels.
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ligand-receptor binding) and sodium concentration in the
incubation medium showed a sigmoid pattern with a maxi-
mum rate of increase for sodium concentrations ranging
between 154 and 308 mmol/L, which corresponded to a
4-fold increase in ET-1 binding efficiency (Figure 7). The
enhancement of binding efficiency was not attributable to
chloride because similar results were obtained when
NaH2PO4 was used instead of NaCl (Figure 7).
Discussion
The present study shows that during low sodium diet (1) the
synthesis of renal ppET-1 is increased mainly in the cortex,
where no changes in endothelin receptors occur, whereas (2)
ETB receptor density selectively increases in renal medulla,
and, moreover, that (3) sodium in vitro directly enhance ETB
receptor density and affinity.
Increased ppET-1 mRNA expression in the endothelial
cells of the peritubular capillary network and in epithelial
cells of the medullary collecting tubules during low sodium
diet was previously reported by our group.2 In the same study,
the increased ppET-1 mRNA expression was associated with
an increased renal ET-1 production and urinary ET-1 excre-
tion linearly related to sodium retention.2 The present study
extends these results and offers new insights into the role of
ET-1 in sodium retentive states in humans. The comparison
between cortex and renal medulla of ppET-1 mRNA expres-
sion at RT-PCR shows that, during low sodium diet, the
ppET-1 gene is enhanced to a greater extent in renal cortex,
where the vascular component is highly represented, than in
renal medulla. Moreover, mRNA studies performed in corti-
cal tissue have revealed that the ETA receptor, previously
found in homogenates from renal cortex,20,21 is mainly
localized in the vasculature (in situ hybridization) and is not
downregulated during low sodium diet (RT-PCR studies).
Sodium reabsorption mainly occurs at the proximal tubule
with an active process. In addition, when extracellular vol-
ume is contracted, as during low sodium diet, and postglo-
merular resistances are increased to maintain the glomerular
filtration rate, the decreased hydrostatic pressure and the
increased colloid osmotic pressure in peritubular capillaries
further enhance the rate of sodium reabsorption at the
proximal tubule. The wide range of increase in ppET-1
expression in renal cortex (194%) might contribute to






Tris Buffer Tris BufferNaCla Tris Buffer Tris BufferNaCla
Cortex
Bmax total, fmol/mg 599 12112* 6111 13016*
ETAETB 1882 1189 1684 991
ETA, fmol/mg 112 131 102 121
ETB, fmol/mg 497 10710* 519 11814*
Kd ET-1, pmol/L 5514 132* 476 155*
Kobs, min1 0.0640.012 0.1060.010* 0.0650.015 0.1030.018*
K-1, min1 0.00760.0019 0.00340.0005* 0.00660.0008 0.00380.0005*
Medulla
Bmax total, fmol/mg 12713† 18218*† 18426‡† 27917*‡†
ETAETB 1288 892 694 595
ETA, fmol/mg 152 151 113 141
ETB, fmol/mg 11212† 16717*† 17324‡† 26517*‡†
Kd ET-1, pmol/L 3817 103* 3211 124*
Kobs, min1 0.0430.010 0.0970.032* 0.0600.007 0.0950.023*
K-1, min1 0.00630.0019 0.00290.0008* 0.00600.0011 0.00330.0007*
Bmax indicates maximum binding; Kd ET-1, dissociation constant of ET-1; Kobs, kinetically derived
observed association rate constant; K-1, kinetically derived dissociation rate constant.
aThe effect of local sodium concentration on ET-1 binding is investigated in vitro in the presence
of 308 mmol/L NaCl.
*P0.05 vs Tris-buffer; †P0.05 vs cortex; ‡P0.05 vs normal sodium intake.
Figure 3. Competition experiments in human renal cortex (A)
and medulla (B) of patients on normal sodium diet (n6). ET-1
(filled circles), BQ123 (empty circles). Experiments are per-
formed in triplicate.
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reducing cortical blood flow through ETA receptors,4,5,22
enhancing sodium and water reabsorption at the proximal
tubule. The reduction in cortical blood flow also attenuates
the flow in the vasa recta, so that the reduced washout of
osmolytes in renal medulla increases intratubular sodium
concentration and passive sodium reabsorption at the thin
ascending limb of Henle’s loop.23,24
Therefore, the high ppET-1 overexpression in the cortex at
low sodium diet, without changes in vascular ETA receptor,
indicate that, at normal sodium diet, the ETA receptor popu-
lation exceeds the physiological requirement and that, during
low sodium diet, ET-1 contributes to sodium reabsorption
mainly via the ETA -mediated reduction of cortical blood flow
and, finally, that ET-1 does not downregulate the ETA
receptor.
Unlike in the cortex, in renal medulla the increased ppET-1
transcript (30%) is paralleled by selective ETB receptor gene
overexpression (37%) with selective increase in the number
of ETB binding sites (55%). The mechanisms responsible for
the increased medullary de novo synthesis of ETB receptors
during low sodium diet remain to be investigated, and a
possible role for medulla hyperosmolarity can only be pos-
tulated. In situ hybridization indicates that the ETB receptor
gene in the renal medulla is expressed by epithelial cells of
distal tubules and collecting ducts, where previous autoradio-
graphic studies had localized the receptor protein.19 ETB
receptors in inner medullary collecting ducts mediate the
ET-1 inhibitory effect on AVP-stimulated osmotic water
permeability.6,25,26 In addition, ETB stimulation also inhibits
sodium reabsorption along the thick ascending limb.5,27 ETB-
selective overexpression in the renal medulla during low
sodium diet may modulate ETA-mediated sodium retention, at
the same time contrasting AVP-mediated water reabsorption
and possible hyponatremia in clinical conditions character-
ized by nonosmotic AVP secretion, such as heart failure.
During a low sodium diet, the efficiency of ETB receptor
binding in renal medulla also appears to be magnified, in
addition to increased ETB receptor synthesis. In vitro studies
have indeed shown a direct effect of increased local sodium
concentration on ETB receptor density and affinity in medul-
lary membranes. The maximum effect of sodium on ETB
receptors in vitro is evident between 154 and 308 mmol/L
Figure 5. Binding of ET-1 at equilibrium to cortical (upper part)
or medullary (lower part) membranes of kidneys obtained after
normal (filled circles, n6) or low sodium diet (empty circles,
n6). Experiments were performed in triplicate.
Figure 6. Effect of increasing sodium concentration on the
association and dissociation phases of the ET-1 binding to
membranes from renal medulla of patients on normal sodium
diet (n6). Experiments were performed in triplicate.
Figure 4. Representative mRNA expres-
sion of the components of the ET-1 sys-
tem (ppET-1, ECE-1, and ETA and ETB
receptors) after normal (108 mmol/d
NaCl) and low sodium diet (20 mmol/d
NaCl) in renal cortex (upper panels) and
in renal medulla (lower panels). The right
graphs represent the increase in mRNAs
(expressed as ratio to GAPDH) during
low sodium diet (n6) compared with
normal sodium diet (n6). All RT-PCR
studies were performed in triplicate in all
subjects investigated.
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(Figure 7), ie, within the range of sodium concentration in
renal medulla.28 This effect is observed in membranes ob-
tained from patients at both low and normal sodium diet and
is not due to chloride in itself because the same pattern of
response is observed when sodium phosphate is used.
The adaptation of ETB receptors to different sodium intake
is not an isolated result. Type I angiotensin (Ang) II receptors
in the kidney also exhibit physiological adaptation during
chronic changes in sodium intake because sodium restriction
increased renal Ang II receptor density and AT1 mRNA
levels in the 2 main sites of sodium reabsorption, proximal
tubules29,30 and the medullary thick ascending limb of loop of
Henle.31 Conversely, a high salt diet was associated with a
downregulation of AT1 receptors.32 Therefore, during low
sodium diet the upregulation of angiotensin II receptors
cooperates with angiotensin II formation to enhance sodium
retention. In the same condition, the endothelin-1 system
seems to operate as a modulating system because it selec-
tively activates the ETB receptor subtype, which causes
natriuresis and increases free water clearance.
Experiments performed in rats indicated that AT1 receptor
upregulation during low sodium diet is Ang II–dependent
because it was prevented by losartan treatment.31 At variance
with Ang II, endothelin-1 seems not responsible for receptor
upregulation because, according to the present findings, ETB
receptor is not enhanced in the cortex where ET-1 is overex-
pressed to a greater extent than in medulla. Moreover, the in
vivo increase in ETB receptor binding efficiency during low
sodium diet is reproduced in vitro by sodium concentrations
expected to be present in renal medulla. Sodium was reported
to interact at the level of the second transmembrane domain
of the other 7 membrane domain receptors, such as the D2
receptor33 and the bradykinin B2 receptor,34 resulting in
enhanced stability of the agonist-receptor complex and en-
hanced binding efficiency.35 The present study does not
clarify the responsible mechanism at the molecular level but,
for the first time, indicates that only the type B of the 2
endothelin receptors dynamically adapts its binding effi-
ciency in a range of sodium concentration that is physiolog-
ical for renal medulla.
In conclusion, present findings indicate that the endothelin
system in the kidney is regulated by sodium intake and that
the local levels of sodium directly modulate ETB receptor
density and affinity, resulting in a different adaptations of the
cortex and renal medulla to low sodium diet.
Perspectives
The enhanced ET-1 synthesis with increased efficiency of the
ETB receptor in human renal medulla during low sodium diet
shows a dynamic modulation of the renal ET-1 system in a
physiological condition of sodium retention. ETB enhances
free water clearance so that medullary ETB receptor adapta-
tion might indeed play a key role in counteracting cortical
ETA-mediated sodium retention and AVP-mediated water
reabsorption in sodium retentive states.
These results might also bear implications for the proposed
therapeutic use of endothelin receptor antagonist in heart
failure. Notwithstanding the fact that acute nonselective ET-1
antagonism showed hemodynamic benefits in heart failure
patients,36,37 the ETB blockade might be responsible for the
early and sustained increase in body weight and frequency of
edema caused by fluid retention, recently observed during
chronic mixed ETA/ETB receptor blockade.38 It is worth
recalling that, in experimental heart failure, only the use of
selective ETA antagonists was shown to improve diuresis,
whereas no effects were observed following the administra-
tion of nonselective ET-1 antagonists.39,40 Therefore, the
enhanced ETB efficiency might play a relevant role, espe-
cially under conditions of marked sodium retention.
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